SYSTEMATIC REVIEW OF LONG-ACTING INJECTABLES (LAI) VERSUS ORAL ATYPICAL ANTIPSYCHOTICS (OA) ON HOSPITALIZATION IN SCHIZOPHRENIA

Author(s)

Lafeuille M1, Cloutier M1, Fortier J1, Duh MS2, Fastenau J3, Dirani R3, Lefebvre P1
1Groupe d’analyse, Ltée, Montréal, QC, Canada, 2Analysis Group, Inc., Boston, MA, USA, 3Janssen Scientific Affairs, LLC, Titusville, NJ, USA

OBJECTIVES: The current study aimed at assessing the impact of LAIs versus OAs on hospitalizations among patients with schizophrenia by conducting a thorough systematic review of studies with different study designs and performing a meta-analysis. METHODS: Using the PubMed database and major psychiatric conference proceedings, a systematic literature review for 01/2000–07/2013 was performed to identify English-language studies evaluating schizophrenia patients treated with atypical antipsychotics. Studies reporting hospitalization rates as a percentage of patients hospitalized or as the number of hospitalizations per-person per-year were selected. A meta-analysis of the percentage decrease in hospitalization rates from baseline during treatment was conducted as a primary analysis. The secondary analysis was a meta-analysis of the absolute rate of hospitalization during follow-up. Pooled treatment-effect estimates were calculated using random-effect models. To account for differences in patient and study-level characteristics between studies, meta-regression analyses were used. Subset analyses further explored the heterogeneity across study designs. No adjustment was made for multiplicity. RESULTS: Fifty-eight studies evaluating 25 arms (LAIs: 13 arms, 4,516 patients; OAs: 12 arms, 23,516 patients) in the primary analysis and 78 arms (LAIs: 12 arms, 4,481 patients; OAs: 66 arms, 96,230 patients) in the secondary analysis were identified. Reduction in hospitalization rates for LAIs was 20.7 percentage points higher than that of OAs (random-effect estimates: LAIs=56.2% vs OAs=35.5%, P=0.023). Controlling for patient and study characteristics, the adjusted percentage reduction in hospitalization rates for LAIs was 26.4 percentage points higher than for OAs (95%CI: 3.3-49.5, P=0.027). As for the secondary analysis, no significant difference between LAIs and OAs was observed (random-effect estimate: -8.6, 95%CI: -18.1-1.0, P=0.077). Subset analyses across type of study yielded consistent results. CONCLUSIONS: Results of this meta-analysis including studies with both interventional and non-interventional designs and using meta-regressions, suggest that LAIs significantly reduce hospitalization rates for schizophrenia patients compared to OAs.

Conference/Value in Health Info

2014-05, ISPOR 2014, Palais des Congres de Montreal

Value in Health, Vol. 17, No. 3 (May 2014)

Code

PMH10

Topic

Clinical Outcomes

Topic Subcategory

Comparative Effectiveness or Efficacy

Disease

Mental Health

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×